Christophe Schmitt
- Hematology top 0.2%
- Genetics top 1%
- Molecular Biology
- Oncology top 10%
- Endocrinology, Diabetes and Metabolism top 5%
- Co-authors
- Gallia G. LevyMidori ShimaJohannes OldenburgJohnny MahlanguRebecca Kruse‐JarresMichael U. CallaghanElina AsikaniusGuy Young
- Topics
- Hemophilia Treatment and Research (33 papers)Platelet Disorders and Treatments (16 papers)Coagulation, Bradykinin, Polyphosphates, and Angioedema (14 papers)
- Cited by
- HematologyGeneticsPharmacology
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Christophe Schmitt
69 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Hematology 2.5k
- Genetics 842
- Molecular Biology 597
- Oncology 377
- Endocrinology, Diabetes and Metabolism 354
Countries citing papers authored by Christophe Schmitt
This map shows the geographic impact of Christophe Schmitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Schmitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Schmitt more than expected).
Fields of papers citing papers by Christophe Schmitt
This network shows the impact of papers produced by Christophe Schmitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Schmitt. The network helps show where Christophe Schmitt may publish in the future.
Co-authorship network of co-authors of Christophe Schmitt
This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Schmitt. A scholar is included among the top collaborators of Christophe Schmitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Schmitt. Christophe Schmitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 6 | |
| 3 | 4 | |
| 4 | 41 | |
| 5 | 7 | |
| 6 | 170 | |
| 7 | 4 | |
| 8 | 2 | |
| 9 | 257 | |
| 10 | Emicizumab Prophylaxis in Hemophilia A with Inhibitorsbreakdown → | 759 |
| 11 | 5 | |
| 12 | 41 | |
| 13 | 8 | |
| 14 | 1 | |
| 15 | 11 | |
| 16 | 5 | |
| 17 | 189 | |
| 18 | 9 | |
| 19 | 44 | |
| 20 | 12 |
About Christophe Schmitt
Christophe Schmitt is a scholar working on Hematology, Genetics and Pharmacology, having authored 73 papers that have together received 3.8k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (33 papers), Platelet Disorders and Treatments (16 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (14 papers). The work is most often cited by research in Hematology (2.5k citations), Genetics (842 citations) and Pharmacology (341 citations). Christophe Schmitt has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Gallia G. Levy, Midori Shima, Johannes Oldenburg, Johnny Mahlangu, Rebecca Kruse‐Jarres, Michael U. Callaghan, Elina Asikanius, Guy Young, Víctor Jiménez‐Yuste and Claude Négrier. Their work appears in journals such as New England Journal of Medicine, Blood and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.